You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Psychiatry, 28 October 2024

Sec. Mood Disorders

Volume 15 - 2024 | https://doi.org/10.3389/fpsyt.2024.1507504

Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?

  • 1. Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Pruszkow, Masovian, Poland

  • 2. KeyClinic, Warsaw, Poland

  • 3. Leszek Giec Upper-Silesian Medical Centre of the Medical University of Silesia, Katowice, Poland

  • 4. Medical University of Warsaw, Warsaw, Masovian, Poland

  • 5. MindHealth, Warsaw, Poland

Article metrics

View details

1

Citations

1,3k

Views

405

Downloads

In the published article, there was an error in the affiliations for authors Magdalena Więdłocha, Piotr Marcinowicz and Agata Szulc. Two affiliations were not disclosed. Authors MW and PM were employed by KeyClinic. Author AS was employed by Mindhealth.

In the published article, there was an error in the Conflict of Interest statement, which previously stated:

“The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The corrected statement appears below:

“Authors MW and PM were employed by the company KeyClinic, a commercial mental health center which provides ketamine treatment, as one of many services. Author AS was employed by the company MindHealth, a commercial psychiatric center. AS was also a member of Janssen Cilag Advisory Board and gave lectures for Janssen Cilag.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

ketamine, esketamine, depression, treatment resistant depression (TRD), borderline personality disorder, ketamine-assisted psychotherapy (KAT)

Citation

Więdłocha M, Marcinowicz P, Komarnicki J, Tobiaszewska M, Dębowska W, Dębowska M and Szulc A (2024) Corrigendum: Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?. Front. Psychiatry 15:1507504. doi: 10.3389/fpsyt.2024.1507504

Received

07 October 2024

Accepted

08 October 2024

Published

28 October 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Magdalena Więdłocha,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics